PE109298A1 - Compuestos heterociclicos inhibidores de metaloproteasas - Google Patents

Compuestos heterociclicos inhibidores de metaloproteasas

Info

Publication number
PE109298A1
PE109298A1 PE1997000772A PE00077297A PE109298A1 PE 109298 A1 PE109298 A1 PE 109298A1 PE 1997000772 A PE1997000772 A PE 1997000772A PE 00077297 A PE00077297 A PE 00077297A PE 109298 A1 PE109298 A1 PE 109298A1
Authority
PE
Peru
Prior art keywords
hetero
aryl
compounds
alkyl
inhibitors
Prior art date
Application number
PE1997000772A
Other languages
English (en)
Inventor
Yetunde Olabisi Taiwo
Neil Gregory Almstead
Rimma Sandler Bradley
Gary Steven Garrett
Ii John Emory Marlin
John Mcmillan Mciver
Biswanath De
Zhe Wang
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE109298A1 publication Critical patent/PE109298A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Abstract

SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: Ar ES ALQUILO, ARILO, CARBOCICLO, HETEROCICLO O HETEROARILO; "W" ES O o S; "Y" ES H, OH, OXO, ENTRE OTROS; "Z" ES (CH2)m(CR1R2)oSR3, -(SH)CHCH2COOCH3 o -(SH)CHCH2SR3; R1 ES H, ALQUILO, CH2SR3, CH2C(W)R4; R2 ES H, ALQUILO, CICLOALQUILO, ENTRE OTROS; R3 ES H, ALQUILO, ARILO, ENTRE OTROS, DE PREFERENCIA ES HETEROARILO; R4 ES ALCOXI, OH, NR5, ALQUILTIO o TIO; R5 ES HETEROCICLILALQUILO, ALQUILO, ARILO, ENTRE OTROS; n ES 1; 2 o 3, DE PREFERENCIA n ES 2; m Y o SON 0; 1 o 2. LOS COMPUESTOS DE FORMULA (I) ACTUAN COMO INHIBIDORES DE LAS ENZIMAS METALOPROTEASAS DE LA MATRIZ, SIENDO UTILES EN EL TRATAMIENTO DE ARTRITIS REUMATOIDEA, OSTEOARTRITIS, METASTASIS DE LAS CELULAS DEL TUMOR, DESORDENES CARDIOVASCULARES, DESORDENES OCULARES Y LESIONES ULCERATIVAS, ENTRE OTROS
PE1997000772A 1996-08-28 1997-08-28 Compuestos heterociclicos inhibidores de metaloproteasas PE109298A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2474696P 1996-08-28 1996-08-28

Publications (1)

Publication Number Publication Date
PE109298A1 true PE109298A1 (es) 1999-01-31

Family

ID=21822181

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000772A PE109298A1 (es) 1996-08-28 1997-08-28 Compuestos heterociclicos inhibidores de metaloproteasas

Country Status (20)

Country Link
US (1) US6121272A (es)
EP (1) EP0923547A1 (es)
JP (1) JP2000516954A (es)
KR (1) KR20000035921A (es)
CN (1) CN1228767A (es)
AU (1) AU4074097A (es)
BR (1) BR9712792A (es)
CA (1) CA2263914A1 (es)
CO (1) CO5420196A1 (es)
CZ (1) CZ62499A3 (es)
HU (1) HUP0000616A2 (es)
ID (1) ID18417A (es)
IL (1) IL128665A0 (es)
NO (1) NO990896L (es)
PE (1) PE109298A1 (es)
PL (1) PL331803A1 (es)
SK (1) SK24899A3 (es)
TR (1) TR199900401T2 (es)
WO (1) WO1998008814A1 (es)
ZA (1) ZA977697B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513484A (ja) 1997-07-31 2001-09-04 ザ プロクター アンド ギャンブル カンパニー 非環式メタロプロテアーゼ阻害剤
US6410580B1 (en) 1998-02-04 2002-06-25 Novartis Ag Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
HUP0101176A3 (en) 1998-02-04 2002-06-28 Novartis Ag Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases, process for their preparation and pharmaceutical compositions containing them
US6846478B1 (en) 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
CN1295561A (zh) 1998-06-03 2001-05-16 Gpinil控股公司 N－杂环羧酸或羧酸等排物的n－结合氨磺酰
CA2344412A1 (en) 1998-09-21 2000-03-30 Takeda Chemical Industries, Ltd. Thiol compound, their production and use
BR0009244A (pt) 1999-03-03 2002-04-16 Procter & Gamble Inibidores de metaloprotease di-hétero substituìdos
HUP0202199A2 (en) 1999-03-03 2002-10-28 Procter & Gamble Alkenyl- and alkynyl-containing metalloprotease inhibitors
AU6499000A (en) * 1999-08-05 2001-03-05 Procter & Gamble Company, The Multivalent compounds
AU6388500A (en) * 1999-08-05 2001-03-05 Procter & Gamble Company, The Multivalent sulfonamides
PE20020102A1 (es) 2000-06-30 2002-03-06 Procter & Gamble Composicion topica oral que comprende un agente modulador de la respuesta del huesped frente a patogenos periodontales
US8283135B2 (en) 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
AU7847901A (en) * 2000-07-19 2002-02-05 Hoffmann La Roche Pyrrolidine derivatives as metalloprotease inhibitors
BR0112580A (pt) * 2000-07-19 2003-06-17 Hoffmann La Roche Compostos, composições farmacêuticas que contêm os mesmos, utilização desses compostos, processo para tratamento terapêutico e/ou profilático e processo para a preparação desses compostos
BR0112656A (pt) * 2000-07-19 2003-06-24 Hoffmann La Roche Compostos, composições farmacêuticas que contêm os mesmos, utilização desses compostos,: processo para tratamento terapêutico e/ou profilático e processo para a preparação desses compostos
FR2819252A1 (fr) * 2001-01-11 2002-07-12 Servier Lab Nouveaux derives d'acide hydroxamique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1404325A2 (en) * 2001-05-29 2004-04-07 Guilford Pharmaceuticals Inc. Method for treating nerve injury caused by surgery
WO2004056766A1 (en) * 2002-12-19 2004-07-08 Vertex Pharmaceuticals Incorporated Inhibitors of tace
WO2008130718A1 (en) 2007-04-23 2008-10-30 Atherogenics, Inc. Sulfonamide containing compounds for treatment of inflammatory disorders
CN106905183B (zh) * 2017-02-24 2018-07-31 三峡大学 一类含氨基的ɑ-酰氧基羰基酰胺类衍生物，制备方法及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3501489A (en) * 1966-01-21 1970-03-17 American Home Prod 1-phenylsulfonyl-2-(2-thiazolin-2-yl-oxy and thiol) pyrrolidines
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
IL74140A (en) * 1984-04-10 1988-05-31 Robins Co Inc A H Substituted n-((amino)alkyl)-1-pyrrolidine,-1-piperidine and-1-homopiperidine-carboxamides and pharmaceutical compositions containing them
US4595700A (en) * 1984-12-21 1986-06-17 G. D. Searle & Co. Thiol based collagenase inhibitors
GB8515934D0 (en) * 1985-06-24 1985-07-24 Janssen Pharmaceutica Nv (4-piperidinomethyl and-hetero)purines
IT1215590B (it) * 1987-06-29 1990-02-14 Roussel Maestretti Spa Derivati della 1-benzene solfonil 2-oco 5-alchiltio pirrolidina, un loro procedimentodi preparazione e il loro impiegocome stostanze medicinali.
GB8814813D0 (en) * 1988-06-22 1988-07-27 Beecham Group Plc Novel compounds
DE4011172A1 (de) * 1990-04-06 1991-10-10 Degussa Verbindungen zur bekaempfung von pflanzenkrankheiten
DK0471236T3 (da) * 1990-07-30 1995-07-24 Takeda Chemical Industries Ltd Imidazopyridinderivater og deres anvendelse
JPH05125029A (ja) * 1991-11-06 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアミド化合物又はその塩
US6090785A (en) * 1992-10-15 2000-07-18 Merck & Co., Inc. Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative agents
US5455258A (en) * 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5470834A (en) * 1993-10-06 1995-11-28 Florida State University Sulfoximine and suldodiimine matrix metalloproteinase inhibitors
US5455262A (en) * 1993-10-06 1995-10-03 Florida State University Mercaptosulfide metalloproteinase inhibitors
GB2303850B (en) * 1994-06-22 1998-06-10 British Biotech Pharm Metalloproteinase inhibitors
PT848004E (pt) * 1995-07-31 2003-07-31 Shionogi & Co Derivados pirrolidina tendo actividade inibidora da fosfolipase a2
US6153757A (en) * 1995-12-08 2000-11-28 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors and intermediates useful for their preparation

Also Published As

Publication number Publication date
PL331803A1 (en) 1999-08-02
CN1228767A (zh) 1999-09-15
JP2000516954A (ja) 2000-12-19
HUP0000616A2 (en) 2000-07-28
ZA977697B (en) 1998-02-23
US6121272A (en) 2000-09-19
BR9712792A (pt) 1999-12-14
SK24899A3 (en) 2000-04-10
CZ62499A3 (cs) 1999-07-14
CA2263914A1 (en) 1998-03-05
CO5420196A1 (es) 2004-07-30
ID18417A (id) 1998-04-09
IL128665A0 (en) 2000-01-31
EP0923547A1 (en) 1999-06-23
AU4074097A (en) 1998-03-19
NO990896D0 (no) 1999-02-25
TR199900401T2 (xx) 1999-05-21
KR20000035921A (ko) 2000-06-26
WO1998008814A1 (en) 1998-03-05
NO990896L (no) 1999-04-20

Similar Documents

Publication Publication Date Title
PE109298A1 (es) Compuestos heterociclicos inhibidores de metaloproteasas
PE108998A1 (es) Compuestos heterociclicos inhibidores de metaloproteasas
DE60015927D1 (en) Phenylharnstoff und phenylthioharnstoffderivate
PE2599A1 (es) Compuesto heterociclo inhibidor de metaloproteasa
MY110226A (en) Therapeutic heterocyclic compounds.
DE69021679D1 (de) Verwendung von Bis(3,4-Dialkylbenzyliden)sorbitolacetale und diese enthaltende Zusammensetzungen.
ES2111654T3 (es) Derivados de piperazina como antagonistas de 5-ht1a.
PE34297A1 (es) Ligandos especificos del neuropeptido y1
DE68908737D1 (de) Imidazol-Verbindungen und diese enthaltende Textilbehandlungs-Zusammenstellungen.
ATE324113T1 (de) Verwendung von 2,6-dialkyl-4-silyl-phenol derivaten zur behandlung von xanthom
GEP19991779B (en) Use of Aminoadamantane Compounds as Immunoregulators
NZ331618A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
DE3784642D1 (de) Verwendung von aromatischen carbonsaeureamiden.
DE69921180D1 (de) Künstliche matrix-anheftungsregion zur erhöhung der expression von in pflanzen eingeführten genen
DE69810800T2 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
FI875145A (fi) Kondenserade heterocykliska tetrahydroaminokinoliner och beslaektade foereningar, en metod foer deras framstaellning och deras anvaendning som mediciner.
ATE177103T1 (de) Bicycloaliphatische 2-methylen-1,3-dioxepane
GR3023757T3 (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents.
ES471769A1 (es) Procedimiento para la obtencion de penicilinas
UY24009A1 (es) Compuestos ariltio útiles como agentes antivirales y antibacteriales
BR9707321A (pt) Dihidrobenzofurano e compostor correlatos úteis como agentes antinflamatórios
ES439856A1 (es) Un procedimiento para la preparacion de nuevos eteres basi- cos.
FR2491470B1 (es)
ATE241976T1 (de) N,n'-bis (sulfonyl) hydrazine die als antineoplastische mittel nützlich sind
ATE245643T1 (de) Substituierte isoxazolylthiophenverbindungen

Legal Events

Date Code Title Description
FX Voluntary withdrawal